- Home
- Equipment
- usa massachusetts
- drug analysis and development
Show results for
Refine by
Drug Analysis And Development Equipment Supplied In Usa Massachusetts
29 equipment items found
Manufactured by:TCI America based inPortland, OREGON (USA)
Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ...
Manufactured by:TCI America based inPortland, OREGON (USA)
Product Number: M2291. Purity / Analysis Method: >98.0%(T)(HPLC). Molecular Formula / Molecular Weight: C11H15N5O4 = 281.27. Physical State (20 deg.C): Solid. Storage ...
Manufactured by:TCI America based inPortland, OREGON (USA)
Product Number: M2317. Purity / Analysis Method: >98.0%(T)(HPLC). Molecular Formula / Molecular Weight: C10H15N3O5 = 257.25. Physical State (20 deg.C): Solid. Storage Temperature: 0-10°C. Condition to Avoid: Heat Sensitive. CAS RN: 2140-72-9. Reaxys Registry Number: 619844. PubChem Substance ID: 160871313. MDL Number : MFCD00056067. ...
Manufactured by:Novo Nordisk A/S based inBagsværd, DENMARK
Our proprietary GalXC technology leverages a naturally occurring biologic process, ribonucleic acid interference, RNAi, to create therapies that silence disease-causing genes. This platform enables Dicerna to create molecules that can effectively interfere with the RNAi processes that lead to defective or misregulated proteins that cause disease. ...
Manufactured by:TCI America based inPortland, OREGON (USA)
Product Number: B0578. Molecular Formula / Molecular Weight: C21H14Br4O5S = 698.01. Physical State (20 deg.C): Solid. Packaging and Container: 1G-Glass Bottle with Plastic Insert (View image). CAS RN: 76-60-8. Reaxys Registry Number: 372527. PubChem Substance ID: 87563595. SDBS (AIST Spectral DB): 1768. Merck Index (14): 1386. MDL Number: ...
Manufactured by:Pion based inBillerica, MASSACHUSETTS (USA)
The SDi2 Flow Through Dissolution System integrates high-resolution visible and UV imaging to examine drug dissolution behaviors in real-time. Aimed at drug formulation and development, it offers dual wavelength capacity and compact Raman-compatible flow cells for comprehensive analysis. Scientists can observe physical ...
Manufactured by:Suono Bio based inFoxborough, MASSACHUSETTS (USA)
We have reimagined ultrasound as a simple and effective delivery platform, which acts on the therapeutic molecules themselves, achieving ultra-rapid, formulation-independent drug delivery. This enables us to “push” virtually any therapeutic class, including temperamental molecules, like nucleic acids, directly into cells with astounding efficacy and accuracy, affecting historically ...
Manufactured by:TCI America based inPortland, OREGON (USA)
Product Number: M2290. Purity / Analysis Method: >98.0%(T)(HPLC). Molecular Formula / Molecular Weight: C10H14N2O6 = 258.23. Physical State (20 deg.C): Solid. Storage Temperature: 0-10°C. Condition to Avoid: Heat Sensitive. Packaging and Container: 1G-Glass Bottle with Plastic Insert. CAS RN: 2140-76-3. Reaxys Registry Number: 755710. PubChem Substance ID: 135727332. MDL Number ...
Manufactured by:TCI America based inPortland, OREGON (USA)
Product Number: M2318. Purity / Analysis Method: >98.0%(T)(HPLC). Molecular Formula / Molecular Weight: C11H15N5O5 = 297.27. Physical State (20 deg.C): Solid. Storage Temperature: 0-10°C. Condition to Avoid: Heat Sensitive. Packaging and Container: 200MG-Glass Bottle with Plastic Insert (View image). CAS RN: 2140-71-8. Reaxys Registry Number: 1227554. PubChem Substance ID: 160871355. MDL ...
by:Verb Biotics based inBoston, MASSACHUSETTS (USA)
Yso3 is a preclinical drug development program aimed at treating asthma. Using a revolutionary form of living biotherapy targeting the lung, YSOPIA is pioneering the innovative field of the lung microbiome. As part of this program, YSOPIA has selected a clinical candidate having demonstrated strong in vivo efficacy on inflammation and lung functions. We have achieved the formulation feasibility ...
Manufactured by:Ivenix, Inc. based inNorth Andover, MASSACHUSETTS (USA)
Pharmacists are healthcare’s medication experts. While they play an important role within the infusion process, typically hospitals are unable to reap the full benefits of their deep pharmaceutical knowledge throughout this process – once a drug library is deployed or an I.V. medication leaves the Pharmacy, there is little to no visibility of library compliance, administration, or ...
Manufactured by:TCI America based inPortland, OREGON (USA)
Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ...
Manufactured by:Ariana Pharma based inParis, FRANCE
Ariana Pharma has developed KEM® (Knowledge Extraction and Management) the most advanced Explainable Artificial Intelligence platform based on Galois Lattices (also known as Formal Concept Analysis or FCA). KEM® uses association rules to fully explore complex datasets in order to reveal hidden relationships and to derive new hypotheses. Ariana’s eXplainable Al reduces billions of ...
Manufactured by:Sage Therapeutics based inCambridge, MASSACHUSETTS (USA)
The human brain is a network of billions of nerve cells, connected in complex electrical circuits to communicate. Brain health and function depend on these circuits. The flow of information among these circuits is managed by neural regulatory pathways including the GABA and NMDA receptors ...
Manufactured by:Kalaris based inWaltham, MASSACHUSETTS (USA)
Kalaris Therapeutics is focused on developing innovative treatments for retinal diseases, aiming to reduce the burden of frequent clinical visits for patients with retinal neovascular and exudative conditions. Their lead product, TH103, is a fully humanized, recombinant fusion protein designed for intravitreal delivery as an anti-VEGF agent. TH103 functions as a soluble decoy receptor, ...
Manufactured by:Ariana Pharma based inParis, FRANCE
Ariana® has consolidated multiple, publicly available administrative healthcare admissions databases into a locally searchable observational health data resource of patient hospitalization, outpatient and other episodes, comprising in excess of 6B records. ...
Manufactured by:JPT Peptide Technologies GmbH based inBerlin, GERMANY
Clinical peptides and PepMix Peptide Pools are increasingly needed as antigen source for clinical immune monitoring, diagnostics, cell therapy and vaccine development. The diversity of applications and regulatory requirements calls for a flexible, high quality peptide partner. JPT is that partner with its outstanding know-how on peptide antigen formats, peptide specifications and formulation, ...
Manufactured by:Finch Therapeutics Group, Inc. based inSomerville, MASSACHUSETTS (USA)
Our lead product candidate, CP101, is an orally administered, Complete Consortia product candidate initially targeting the prevention of recurrent CDI. The Centers for Disease Control and Prevention considers CDI to be one of the top three most urgent antibiotic resistant threats and the most common cause of healthcare associated infection in the United ...
Manufactured by:Pion based inBillerica, MASSACHUSETTS (USA)
The Scissor N3 is an advanced in vitro model designed to simulate the subcutaneous injection of biopharmaceuticals. This device is particularly useful during the formulation development phase, enabling researchers to perform rank ordering of formulations and excipient screening. It allows for a thorough understanding of how a drug behaves post subcutaneous ...
by:Intellia Therapeutics, Inc. based inCambridge, MASSACHUSETTS (USA)
Genome editing is efficient, precise and scalable. CRISPR/Cas9 genome editing can make permanent, precisely targeted changes in patients’ chromosomes and repair the underlying genetic mutation, whereas more traditional gene therapy typically involves introducing a non-permanent copy of a gene into patients’ cells. These attributes of CRISPR/Cas9 provide a significant therapeutic edge ...